PMID: 4907811Feb 21, 1970Paper

Controlled trial of propranolol in hypertension

British Medical Journal
F J Zacharias, K J Cowen

Abstract

A trial of oral propranolol as a hypotensive agent was designed to provide adequate treatment periods. Twenty-eight patients with essential hypertension, with a mean blood pressure of 190/111 mm. Hg, were controlled on 120-320 mg. of propranolol daily. Their mean treated blood pressure was 153/91. They then entered, on a randomized and double-blind basis, a cross-over trial of two 16-week periods, blood pressure being measured fortnightly. Propranolol caused a statistically significant fall in blood pressure when compared with placebo. When propranolol was withdrawn blood pressures rapidly rose to hypertensive levels, though not to untreated levels. No postural hypotension was found, but a small change in blood pressure levels on exercise was noted.

References

Nov 26, 1966·Lancet·J W Paterson, C T Dollery
Apr 1, 1968·Circulation·D W RichardsonL W Preston
Mar 1, 1968·Circulation·E D FrohlichI H Page
Jul 1, 1968·Postgraduate Medical Journal·S N Tewari, R H Grant
Jan 4, 1969·British Medical Journal·B N Prichard, P M Gillam
May 9, 1964·British Medical Journal·B N PRICHARD

❮ Previous
Next ❯

Citations

Aug 1, 1979·Journal of Clinical Pharmacology·J E Scrazzolo, A G Queirol
Dec 19, 1975·European Journal of Clinical Pharmacology·G G GeyskesE J Mees
Jan 1, 1975·European Journal of Clinical Pharmacology·M MotoleseA Colombi
Feb 1, 1973·European Journal of Pharmacology·R K SrivastavaK P Bhargava
Sep 1, 1975·European Journal of Pharmacology·H L Garvey, N Ram
Jan 1, 1980·Pharmacology & Therapeutics·B N Prichard, C W Owens
Mar 23, 1972·The New England Journal of Medicine·R ZacestJ Koch-Weser
May 20, 1972·British Medical Journal·F D ThompsonD M Foulkes
Nov 7, 1970·British Medical Journal·A W LeishmanR A Dixon
Dec 15, 1973·British Medical Journal·A J Boakes, B H Boeree
Dec 28, 1977·European Journal of Clinical Pharmacology·C L van HerwaardenA van't Laar
Jan 1, 1980·Current Medical Research and Opinion·A D Broadhurst
Jan 1, 1975·Clinical Toxicology·J E Turner, R H Cravey
Jan 1, 1976·Current Medical Research and Opinion·W L Ashton
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·A F Aderounmu
Jun 1, 1972·American Heart Journal·F J ZachariasB G Wall
Jan 1, 1979·Current Problems in Cardiology·C V Ram, N M Kaplan
Sep 1, 1973·The American Journal of Medicine·V DeQuattro, Y Miura
Nov 10, 1983·The American Journal of Cardiology·U Thadani
Jul 1, 1974·Clinical and Experimental Pharmacology & Physiology·M D Day, A G Roach
Oct 1, 1972·British Heart Journal·E T O'Brien, J MacKinnon
Apr 11, 1976·British Journal of Haematology·S R Weinberg, F Stohlman
Oct 1, 1978·Scottish Medical Journal·E B Raftery
Jan 1, 1978·The Journal of International Medical Research·N Jaroonvesma, K Charoenlarp
Dec 1, 1971·Acta Medica Scandinavica·L HanssonA Westerlund
Jan 1, 1977·The Journal of International Medical Research·R B DeeringL J Ison
Jun 1, 1973·Acta Medica Scandinavica·G Berglund, L Hansson
Jan 1, 1982·British Journal of Clinical Pharmacology·B N Prichard
Apr 1, 1972·Klinische Wochenschrift·L HanssonB Hood
Jan 1, 1974·Acta Medica Scandinavica. Supplementum·T SomerM H Frick
Oct 1, 1972·Scottish Medical Journal·I MitchellA A Lawson
Apr 1, 1986·The Journal of Pharmacy and Pharmacology·M K Davies, J McAinsh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.